We have established that the endpoint genotyping method Kompetitive Allele Specific PCR (KASPTM) is a fast, reliable method for the screening of meningioma samples into different non-NF2 mutational groups using a standard real-time PCR instrument. This evidence concerns the gene NF2 and meningioma.